Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Bilateral Nasal Polyposis: later-stage trial registry
1 of 2 indexed Bilateral Nasal Polyposis trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #7,188 of 28,707 conditions by registered trial count.
2 US clinical trials · 1 currently recruiting · #7,188 of 28,707 conditions by registered trial count
Bilateral Nasal Polyposis: 2 US clinical trials tracked, 1 recruiting.
Bilateral Nasal Polyposis is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Optinose US, running 2 of these trials.
Enrollment posture brief
Registry condition bilateral-nasal-polyposis
OPEN 1 | RECR 50% | LATE 2 | EARLY 0 | RANK #7188 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)
Bilateral Nasal Polyposis lists 1 open slots (50% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Bilateral Nasal Polyposis on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Bilateral Nasal Polyposis is recruiting above its size-band peers.
1 of 2 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
2 total, page 1 of 1
OPN-375 Efficacy and Safety in Adolescents With Bilateral Nasal Polyps
Optinose US
NCT03747458
Efficacy and Safety Study of Intranasal Administration of 100, 200, and 400 μg of Fluticasone Propionate Using a Novel Bi-directional Device
Optinose US
NCT01624662
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 3 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Bilateral Nasal Polyposis records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Bilateral Nasal Polyposis trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Bilateral Nasal Polyposis page
2 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Bilateral Nasal Polyposis trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Optinose US sponsors the most Bilateral Nasal Polyposis trials on record, review their full trial history before evaluating a specific study. See Optinose US's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Bilateral Nasal Polyposis condition card totals 2 registered trials; most-linked intervention Fluticasone propionate; top US site state Kentucky. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.